Case Studies

A 6-year-old boy presented with a high white blood cell count and a mediastinal mass. He was diagnosed with high-risk T-cell acute lymphoblastic leukemia (ALL) and treated in the ALLTogether1 trial1. During induction therapy with regimen B, the patient continued to have high levels of minimal residual disease (MRD). Subsequently,

A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)

A prospective, multi-institutional clinical study supported by the French National Cancer Institute (INCa: Institut National du Cancer) demonstrated that patients with head and neck cancer treated with intensity-modulated radiation therapy (IMRT) showed a significantly better local control rate, cancer-specific survival rate and post-treatment salivary function when treated with Helical TomoTherapy

This case demonstrates the benefits of accurate and fast Accuray Precision® Treatment Planning System with VOLO™ Ultra in a dog with a squamous cell carcinoma in the nasal region

For frail patients with early-stage non-small cell lung cancer (NSCLC), where treatment toxicity and risk mitigation are of paramount importance, the Radixact® System with Synchrony® Lung Tracking™ with Respiratory Modeling is a promising approach to minimize the risk of radiation pneumonitis.

Here we present a case study centred on a patient with prostate cancer receiving hypofractionated treatment using Synchrony® Fiducial Tracking™, a real-time target tracking technology using MLC and jaw motion to correct for target motion. A synthetic CT was used as a reference for dose planning, fiducial recognition and image